Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2073935113', 'doi': 'https://doi.org/10.2169/internalmedicine.53.2578', 'title': 'Molecular Response to Nilotinib in a Patient with Imatinib-intolerant e19a2-positive Chronic Myeloid Leukemia', 'display_name': 'Molecular Response to Nilotinib in a Patient with Imatinib-intolerant e19a2-positive Chronic Myeloid Leukemia', 'publication_year': 2014, 'publication_date': '2014-01-01', 'ids': {'openalex': 'https://openalex.org/W2073935113', 'doi': 'https://doi.org/10.2169/internalmedicine.53.2578', 'mag': '2073935113', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/25500442'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2169/internalmedicine.53.2578', 'pdf_url': 'https://www.jstage.jst.go.jp/article/internalmedicine/53/24/53_53.2578/_pdf', 'source': {'id': 'https://openalex.org/S154471048', 'display_name': 'Internal Medicine', 'issn_l': '0918-2918', 'issn': ['0918-2918', '1349-7235'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313351', 'host_organization_name': 'The Japanese Society of Internal Medicine', 'host_organization_lineage': ['https://openalex.org/P4310313351'], 'host_organization_lineage_names': ['The Japanese Society of Internal Medicine'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://www.jstage.jst.go.jp/article/internalmedicine/53/24/53_53.2578/_pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030271449', 'display_name': 'Tomohiro Kajiguchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210158988', 'display_name': 'Tosei General Hospital', 'ror': 'https://ror.org/04yveyc27', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210158988']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tomohiro Kajiguchi', 'raw_affiliation_strings': ['Department of Hematology and Oncology, Tosei General Hospital, Japan'], 'affiliations': [{'raw_affiliation_string': 'Department of Hematology and Oncology, Tosei General Hospital, Japan', 'institution_ids': ['https://openalex.org/I4210158988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051185785', 'display_name': 'Shingo Okuno', 'orcid': 'https://orcid.org/0000-0002-7477-0986'}, 'institutions': [{'id': 'https://openalex.org/I4210158988', 'display_name': 'Tosei General Hospital', 'ror': 'https://ror.org/04yveyc27', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210158988']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shingo Okuno', 'raw_affiliation_strings': ['Department of Hematology and Oncology, Tosei General Hospital, Japan'], 'affiliations': [{'raw_affiliation_string': 'Department of Hematology and Oncology, Tosei General Hospital, Japan', 'institution_ids': ['https://openalex.org/I4210158988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033592012', 'display_name': 'T Ohno', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210158988', 'display_name': 'Tosei General Hospital', 'ror': 'https://ror.org/04yveyc27', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210158988']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Toshihito Ohno', 'raw_affiliation_strings': ['Department of Hematology and Oncology, Tosei General Hospital, Japan'], 'affiliations': [{'raw_affiliation_string': 'Department of Hematology and Oncology, Tosei General Hospital, Japan', 'institution_ids': ['https://openalex.org/I4210158988']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5019005679', 'display_name': 'Akihiro Abe', 'orcid': 'https://orcid.org/0000-0003-1773-5698'}, 'institutions': [{'id': 'https://openalex.org/I145673806', 'display_name': 'Fujita Health University', 'ror': 'https://ror.org/046f6cx68', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I145673806']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Akihiro Abe', 'raw_affiliation_strings': ['Department of Hematology, Fujita Health University School of Medicine, Japan'], 'affiliations': [{'raw_affiliation_string': 'Department of Hematology, Fujita Health University School of Medicine, Japan', 'institution_ids': ['https://openalex.org/I145673806']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.446, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.579351, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 73, 'max': 77}, 'biblio': {'volume': '53', 'issue': '24', 'first_page': '2801', 'last_page': '2804'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11215', 'display_name': 'Efficacy and Resistance in CML Treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11215', 'display_name': 'Efficacy and Resistance in CML Treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12600', 'display_name': 'Hypereosinophilic Syndrome and Related Disorders', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/molecular-response', 'display_name': 'Molecular Response', 'score': 0.498262}, {'id': 'https://openalex.org/keywords/imatinib-mesylate', 'display_name': 'Imatinib mesylate', 'score': 0.48752043}], 'concepts': [{'id': 'https://openalex.org/C2777413986', 'wikidata': 'https://www.wikidata.org/wiki/Q412327', 'display_name': 'Nilotinib', 'level': 4, 'score': 0.9646408}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9152841}, {'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.88902545}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.83911747}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.68746525}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.633455}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.537213}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.533818}, {'id': 'https://openalex.org/C2779536868', 'wikidata': 'https://www.wikidata.org/wiki/Q419940', 'display_name': 'Dasatinib', 'level': 4, 'score': 0.50329727}, {'id': 'https://openalex.org/C3019892230', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib mesylate', 'level': 4, 'score': 0.48752043}, {'id': 'https://openalex.org/C111829193', 'wikidata': 'https://www.wikidata.org/wiki/Q1108970', 'display_name': 'Fusion gene', 'level': 3, 'score': 0.48017135}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.41198134}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.39022484}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.19846588}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.13484022}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.105394125}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.074204326}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001549', 'descriptor_name': 'Benzamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D015464', 'descriptor_name': 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001549', 'descriptor_name': 'Benzamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016044', 'descriptor_name': 'Fusion Proteins, bcr-abl', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D016044', 'descriptor_name': 'Fusion Proteins, bcr-abl', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068877', 'descriptor_name': 'Imatinib Mesylate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015464', 'descriptor_name': 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2169/internalmedicine.53.2578', 'pdf_url': 'https://www.jstage.jst.go.jp/article/internalmedicine/53/24/53_53.2578/_pdf', 'source': {'id': 'https://openalex.org/S154471048', 'display_name': 'Internal Medicine', 'issn_l': '0918-2918', 'issn': ['0918-2918', '1349-7235'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313351', 'host_organization_name': 'The Japanese Society of Internal Medicine', 'host_organization_lineage': ['https://openalex.org/P4310313351'], 'host_organization_lineage_names': ['The Japanese Society of Internal Medicine'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/25500442', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2169/internalmedicine.53.2578', 'pdf_url': 'https://www.jstage.jst.go.jp/article/internalmedicine/53/24/53_53.2578/_pdf', 'source': {'id': 'https://openalex.org/S154471048', 'display_name': 'Internal Medicine', 'issn_l': '0918-2918', 'issn': ['0918-2918', '1349-7235'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313351', 'host_organization_name': 'The Japanese Society of Internal Medicine', 'host_organization_lineage': ['https://openalex.org/P4310313351'], 'host_organization_lineage_names': ['The Japanese Society of Internal Medicine'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.44, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 26, 'referenced_works': ['https://openalex.org/W120676909', 'https://openalex.org/W1573399247', 'https://openalex.org/W1968747503', 'https://openalex.org/W1978403940', 'https://openalex.org/W1983351391', 'https://openalex.org/W1997026783', 'https://openalex.org/W2001925505', 'https://openalex.org/W2011089259', 'https://openalex.org/W2011672574', 'https://openalex.org/W2018379598', 'https://openalex.org/W2031824081', 'https://openalex.org/W2034623664', 'https://openalex.org/W2053374212', 'https://openalex.org/W2068174949', 'https://openalex.org/W2072834954', 'https://openalex.org/W2074612406', 'https://openalex.org/W2095713049', 'https://openalex.org/W2106555552', 'https://openalex.org/W2124196948', 'https://openalex.org/W2143941105', 'https://openalex.org/W2145335197', 'https://openalex.org/W2163108727', 'https://openalex.org/W2399016944', 'https://openalex.org/W248013826', 'https://openalex.org/W4231877731', 'https://openalex.org/W4243633647'], 'related_works': ['https://openalex.org/W2911387814', 'https://openalex.org/W2763572665', 'https://openalex.org/W2514979974', 'https://openalex.org/W2163329109', 'https://openalex.org/W2155615242', 'https://openalex.org/W2070410089', 'https://openalex.org/W2026325859', 'https://openalex.org/W1992121712', 'https://openalex.org/W1969154832', 'https://openalex.org/W1963599260'], 'abstract_inverted_index': {'The': [0, 13], 'BCR-ABL1': [1], 'fusion': [2], 'gene': [3], 'is': [4, 16], 'the': [5, 68], 'molecular': [6, 56, 71], 'marker': [7], 'of': [8, 27, 34], 'chronic': [9], 'myeloid': [10], 'leukemia': [11], '(CML).': [12], 'e19a2': [14], 'transcript': [15], 'a': [17, 32, 54, 93], 'rare': [18], 'variant': [19], 'associated': [20], 'with': [21, 43], 'various': [22], 'clinical': [23], 'presentations': [24], 'and': [25, 45, 58], 'courses': [26], 'CML.': [28], 'We': [29], 'herein': [30], 'present': [31], 'case': [33], 'e19a2-positive': [35, 82, 98], 'CML': [36, 83, 99], 'who': [37], 'was': [38], 'intolerant': [39], 'to': [40, 48, 63, 67], 'initial': [41], 'treatment': [42, 96], 'imatinib': [44, 74], 'successfully': [46], 'responded': [47], 'subsequent': [49], 'nilotinib': [50], 'therapy.': [51], 'She': [52], 'achieved': [53, 70], 'major': [55], 'response': [57, 72], 'has': [59, 76], 'since': [60], 'be': [61, 92], 'able': [62], 'sustain': [64], 'it.': [65], 'According': [66], 'literature,': [69], 'by': [73], 'monotherapy': [75], 'not': [77], 'yet': [78], 'been': [79], 'reported': [80], 'in': [81], 'patients.': [84, 100], 'Second': [85], 'generation': [86], 'tyrosine': [87], 'kinase': [88], 'inhibitors': [89], 'may': [90], 'therefore': [91], 'more': [94], 'effective': [95], 'for': [97]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2073935113', 'counts_by_year': [{'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-09-25T02:09:12.699987', 'created_date': '2016-06-24'}